How a Life Settlement Appraisal Works: Valuing a Policy Before You Sell

What a Life Settlement Appraisal Actually Is

When a client asks what their life insurance policy is "worth," the honest answer is that it depends on who is buying and why. To the carrier, it is worth the cash surrender value. To the beneficiary, it is worth the death benefit at some unknown future date. To a third-party buyer in the secondary market, it is worth something in between, and estimating that middle number is what a life settlement appraisal does.

An appraisal is not an offer. It is a valuation exercise, closer in spirit to appraising a building or a private business than to getting a quote. It models the economic value a rational buyer would assign to the right to own the policy, pay its future premiums, and eventually collect the death benefit. Done well, it produces a defensible range rather than a single figure and tells an advisor whether taking the policy to market is worth the effort before anyone signs anything.

Important Disclosure

Lumis Life is an analytics platform. We are not a broker, dealer, or life settlement provider. We do not buy policies, sell policies, or receive commissions on life settlement transactions. The tools we build help advisors estimate a policy's economic value using actuarial-grade longevity modeling. The decision about what to do with a policy, and which licensed providers to work with, belongs to the advisor and the client. When this article describes how a policy is "appraised" or "valued," it is describing an estimation method, not a transaction we participate in.

The Four Drivers of Appraised Value

Every life settlement valuation comes down to four inputs. Three are reasonably knowable from policy documents; the fourth is an assumption about the buyer, and understanding how they interact is the whole game.

The Death Benefit

The death benefit, or face amount, is the money the buyer eventually collects. It is the ceiling on the appraisal and, for most policies, the only input that is essentially fixed. A larger death benefit supports a larger appraised value, all else equal. But the face amount is emphatically not the appraised value; it is the gross figure before the costs and timing that determine price, and a common client error is to anchor on it. Where a policy has an increasing death benefit, paid-up additions, or scheduled face reductions, a careful appraisal reflects the projected payout year by year rather than a single headline number.

The Projected Premium Stream

To collect the death benefit, the buyer has to keep the policy in force, which means paying premiums until the insured dies. Those premiums are a cost that reduces the appraised value, and they are far less obvious than the face amount. The question is not "what is the premium today" but "what is the minimum premium required to sustain the policy across the insured's expected lifespan."

This is where policy type matters enormously. A guaranteed universal life or no-lapse guarantee policy has a defined minimum premium schedule, a traditional universal life policy has cost-of-insurance charges that rise with age so the premium needed to prevent a lapse climbs over time, and whole life has a level contractual premium. Modeling this stream correctly is one of the more technical parts of the exercise, and getting it wrong in either direction distorts the valuation. Our deeper treatment of these mechanics lives in the life insurance policy evaluation guide.

The Insured's Life Expectancy

Life expectancy determines two things at once: how many years of premiums the buyer must pay, and how long they wait before the death benefit arrives. Both push the same way. A shorter life expectancy means fewer premiums and a sooner payout, which raises value; a longer one means more premiums and a more heavily discounted payout, which lowers it.

Because it touches both the cost side and the timing side of the calculation, life expectancy is the single most influential variable in the appraisal, and it deserves the closer look it gets below.

The Buyer's Required Rate of Return

The final input is the discount rate, which reflects the return the buyer demands for tying up capital in an asset whose payout date is uncertain. Institutional life settlement buyers are not charities; they price to a target internal rate of return, typically in the low-to-mid teens, to compensate for illiquidity, mortality uncertainty, and servicing costs. A higher required return produces a lower appraised value, because future dollars are discounted more steeply. It is also why two buyers can price the same policy differently, so a good appraisal states the assumed return explicitly rather than pretending there is one correct rate.

Because three of these four inputs carry genuine uncertainty, a credible appraisal reports a confidence range rather than a single, deceptively precise figure. When you see one exact number presented as "the value," treat it with some suspicion.

Why Life Expectancy Is the Central Input

Stripped to a single sentence, the buyer is betting on how long the insured will live, and everything else is arithmetic around that bet.

Consider two clients holding the same $1,000,000 universal life policy with the same premium structure. The first has a health-adjusted life expectancy of 78, so the buyer expects roughly six years of premiums before collecting. The second, at 88, faces sixteen years of premiums and a death benefit discounted over sixteen years. The first policy is worth dramatically more, even though the face amount, premium schedule, and discount rate are identical. The only variable that changed was the expected timeline, and it changed everything.

This is why a health event that seems purely negative for the client can raise what their policy is worth on the secondary market, a point we develop in our guide to when a client should consider a settlement. It is also why precision matters: because value is so sensitive to the timeline, an error of even three to five years can move the appraised value by a wide margin, no matter how sophisticated the discounting around it looks.

Three Numbers That Are Not the Same

Clients routinely conflate three figures that mean very different things, and separating them is one of the most useful things an advisor can do in the first conversation.

The face value, or death benefit, is what the policy pays when the insured dies. It is the largest of the three numbers and the least relevant to today's value, because it ignores both the time until payout and the premiums required to get there.

The cash surrender value is what the issuing carrier will pay to cancel the contract now. It reflects the policy's internal account value net of any surrender charges, and for many older universal life policies it is surprisingly small, sometimes a fraction of the premiums paid. The surrender value is the floor: it is what the client gets by simply handing the policy back to the carrier.

The appraised or settlement value is what a third-party buyer would pay to own the policy. For an eligible policy it sits above the surrender value, often well above it, because the buyer is pricing the death benefit rather than the account value. That gap between surrender value and settlement value is the entire economic reason the secondary market exists.

This relationship is the crux of the settlement case. A settlement offer of $200,000 on a $1,000,000 policy is not "twenty cents on the dollar," because the face value is the wrong benchmark. The right comparison is the offer against the next best alternative, usually the far lower surrender value, and framing it that way keeps the conversation honest.

Which Policies Qualify: The Eligibility Screens

Not every policy is a candidate for appraisal, and valuing one that could never trade wastes everyone's time. A handful of screens filter the field quickly.

Insured age. The secondary market is most active for insureds aged 65 and older. Below that age, life expectancies are long enough that the discounting overwhelms the death benefit and offers are weak, except in cases of serious health impairment. Advanced age works in the client's favor here, not against it.

Policy type. Permanent policies are the natural candidates: universal life and its variants (indexed, variable, and guaranteed UL), along with whole life. Convertible term also qualifies, because the conversion privilege can be exercised to create a permanent policy a buyer can hold. Pure term with no conversion option is generally not settleable, since it expires before the death benefit is ever paid.

Face amount. This is the screen most often misunderstood, so it gets its own section.

What "Minimum Policy Size" Really Means

There is no legal minimum policy size for a life settlement, but there is an economic one, and it comes from fixed transaction costs. Every settlement carries costs that do not shrink with the policy: medical record retrieval, life expectancy underwriting, legal and provider fees, and ongoing servicing. On a small policy, those fixed costs consume so much of the value that the buyer either declines or offers so little the client is better off surrendering.

As a practical matter, that pushes the floor to roughly a $100,000 face amount, and the economics become genuinely attractive above about $250,000, the range often called the sweet spot. A larger policy spreads the same fixed costs over a bigger death benefit, leaving more value for the client, which is why "minimum policy size" is really shorthand for an economic threshold rather than a regulatory one. When an advisor sees a $75,000 policy, the honest answer is usually that the numbers do not support a settlement, and the realistic alternatives are keeping or surrendering it, a trade-off we work through in our keep vs. sell framework.

Why a Health-Adjusted Life Expectancy Produces a More Defensible Appraisal

Because the entire valuation pivots on life expectancy, the quality of that estimate is the difference between a defensible appraisal and a guess, and this is where population mortality tables fall short. A table such as the SSA period life table reports the average remaining years for everyone of a given age and sex. It knows nothing about the insured's specific conditions, family history, or functional status, or the fact that owners of sizable permanent policies tend to be wealthier and longer-lived than average. Feeding that average into a settlement valuation produces a number that is right for a crowd and wrong for the individual in front of you.

An actuarial-grade, health-adjusted life expectancy improves on this in three ways. It incorporates the insured's actual conditions and their interactions rather than assuming an average body. It builds on recognized public standards such as the SOA 2015 Valuation Basic Table and the MP-2021 mortality improvement scale, so the baseline reflects credible industry experience and future improvement. And it expresses the result as a distribution with a confidence range rather than a single point, which is exactly what a discounted-cash-flow valuation needs, because the buyer is pricing a probability of payout in each future year rather than a certainty in one.

The payoff is a valuation that holds up to scrutiny. When a client asks why the appraised value is what it is, "because the estimate accounts for these specific conditions, with this confidence range, built on published mortality standards" is a far stronger answer than "because the table said so."

From Appraisal to Transaction

An appraisal tells you what a policy is likely worth. It does not, by itself, sell anything, and that distinction matters both practically and ethically. If the appraised range comfortably exceeds the surrender value and the client no longer needs the coverage, taking the policy to licensed settlement providers may be worthwhile. If the range is thin or the coverage is still needed, the analysis has done its job by preventing a transaction that would not have served the client.

Advisors can run this valuation through the Lumis Life platform, which produces the health-adjusted life expectancy, models the premium stream and death benefit, and generates the life settlements report that frames the appraised range. What follows, the solicitation of offers, negotiation, and closing, happens between the client and licensed providers regulated for that purpose. Those proceeds also carry tax consequences that belong in any complete analysis; our overview of the tax implications of life settlements explains why the after-tax figure, not the gross offer, is the one that matters. Keeping these roles distinct protects everyone: the advisor gets an independent valuation with no transaction incentive attached, and the client gets an honest number before committing to anything irreversible.

Putting It Together

A life settlement appraisal answers a simple question: what is the right to this future death benefit worth to a buyer today? The answer falls out of four inputs, with life expectancy doing most of the work because it governs both how much the buyer pays in premiums and how long they wait to be paid. The appraised value is distinct from both the face amount and the surrender value, and it exists only for policies that clear the age, type, and size screens that make the transaction economical.

For advisors, the discipline is in the inputs. Get the life expectancy right, with a health-adjusted estimate and a real confidence range, and the rest of the model has something solid to stand on. Anchor it to a population table, and the number that comes out is closer to a guess dressed up as a valuation.

You can see how a client's health profile moves their estimated life expectancy with our free longevity calculator, and advisors who want full policy valuations, including the life expectancy distribution that drives every appraisal, can request access to the platform. Whatever the eventual decision, the client is better served when the appraisal starts from the right number.